Edge Rewrite
restyle Source code View original
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

MDMAT

From Wikipedia, the free encyclopedia

MDMAT
Clinical data
Other names6,7-MDMAT; 6,7-Methylenedioxy-N-methyl-2-aminotetralin
Drug classSerotonin releasing agent; Entactogen
ATC code
  • None
Legal status
Legal status
  • US: Uncontrolled;[1] May fall under the Federal Analogue Act
Identifiers
  • N-Methyl-5,6,7,8-tetrahydrobenzo[f][1,3]benzodioxol-6-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H15NO2
Molar mass205.257 g·mol−1
3D model (JSmol)
  • C3c1cc2OCOc2cc1CCC3NC
  • InChI=1S/C12H15NO2/c1-13-10-3-2-8-5-11-12(15-7-14-11)6-9(8)4-10/h5-6,10,13H,2-4,7H2,1H3 X markN
  • Key:MTRLJTZQUZHTJI-UHFFFAOYSA-N X markN
 X markNcheckY (what is this?)  (verify)

MDMAT, also known as 6,7-methylenedioxy-N-methyl-2-aminotetralin, is a serotonin releasing agent (SRA) and possible entactogen of the 2-aminotetralin family. It is the N-methylated derivative of MDAT, similarly to the relationship of MDMA to MDA.[2][3] It has been theorized to have less long-term neurotoxicity and less hallucinogenic effects than other MDxx derivatives,[4] but no formal scientific research has been conducted specifically on MDMAT.

See also

[edit]

References

[edit]
  1. ↑ "Controlled Substances - Alphabetical Order -" (PDF). Controlled Substances - Alphabetical Order - DEA Diversion Control Division. US Drug Enforcement Agency. Retrieved Aug 17, 2024.
  2. ↑ Violland R, Violland-Duperret N, Pacheco H, Trouiller G, Lebland A (1971). "Potential psychotropic compounds. VIII. Synthesis and pharmacological activity of 2-aminotetralins related to psychomimetics". Chimica Therapeutica. 6 (3): 196.
  3. ↑ Malmusi L, Dukat M, Young R, Teitler M, Darmani NA, Ahmad B, et al. (January 1996). "1,2,3,4-Tetrahydroisoquinoline and related analogs of the phenylalkylamine designer drug MDMA". Medicinal Chemistry Research. 6 (6): 412–26m.
  4. ↑ Nichols DE, Brewster WK, Johnson MP, Oberlender R, Riggs RM (February 1990). "Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA)". Journal of Medicinal Chemistry. 33 (2): 703–710. doi:10.1021/jm00164a037. PMID 1967651.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=MDMAT&oldid=1341021662"